Blish CA - Search Results

1

NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.

Lee MJ, de Los Rios Kobara I, Barnard TR, Vales Torres X, Tobin NH, Ferbas KG, Rimoin AW, Yang OO, Aldrovandi GM, Wilk AJ, Fulcher JA, Blish CA. Lee MJ, et al. Among authors: blish ca. J Immunol. 2024 Jun 1;212(11):1693-1705. doi: 10.4049/jimmunol.2300731. J Immunol. 2024. PMID: 38578283 Free PMC article.

2

The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.

Lynch JB, Nduati R, Blish CA, Richardson BA, Mabuka JM, Jalalian-Lechak Z, John-Stewart G, Overbaugh J. Lynch JB, et al. Among authors: blish ca. J Virol. 2011 Jun;85(11):5252-61. doi: 10.1128/JVI.02216-10. Epub 2011 Mar 16. J Virol. 2011. PMID: 21411521 Free PMC article.

3

Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.

Blish CA, Dogan OC, Derby NR, Nguyen MA, Chohan B, Richardson BA, Overbaugh J. Blish CA, et al. J Virol. 2008 Dec;82(24):12094-103. doi: 10.1128/JVI.01730-08. Epub 2008 Oct 8. J Virol. 2008. PMID: 18842728 Free PMC article.

4

Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes.

Blish CA, Sather DN, Sellhorn G, Stamatatos L, Sun Y, Srivastava I, Barnett SW, Cleveland B, Overbaugh J, Hu SL. Blish CA, et al. J Virol. 2010 Mar;84(5):2573-84. doi: 10.1128/JVI.01687-09. Epub 2009 Dec 16. J Virol. 2010. PMID: 20015987 Free PMC article.

5

HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.

Blish CA, Nedellec R, Mandaliya K, Mosier DE, Overbaugh J. Blish CA, et al. AIDS. 2007 Mar 30;21(6):693-702. doi: 10.1097/QAD.0b013e32805e8727. AIDS. 2007. PMID: 17413690

6

Changes in plasma cytokines after treatment of ascaris lumbricoides infection in individuals with HIV-1 infection.

Blish CA, Sangaré L, Herrin BR, Richardson BA, John-Stewart G, Walson JL. Blish CA, et al. J Infect Dis. 2010 Jun 15;201(12):1816-21. doi: 10.1086/652784. J Infect Dis. 2010. PMID: 20441516 Free PMC article. Clinical Trial.

7

Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.

Blish CA, Nguyen MA, Overbaugh J. Blish CA, et al. PLoS Med. 2008 Jan 3;5(1):e9. doi: 10.1371/journal.pmed.0050009. PLoS Med. 2008. PMID: 18177204 Free PMC article.

8

Loss of cell cycle controls in apoptotic lymphoblasts of the bursa of Fabricius.

Neiman PE, Blish C, Heydt C, Loring G, Thomas SJ. Neiman PE, et al. Mol Biol Cell. 1994 Jul;5(7):763-72. doi: 10.1091/mbc.5.7.763. Mol Biol Cell. 1994. PMID: 7812045 Free PMC article.

9

Hormonal contraception and HIV-1 transmission.

Blish CA, Baeten JM. Blish CA, et al. Am J Reprod Immunol. 2011 Mar;65(3):302-7. doi: 10.1111/j.1600-0897.2010.00930.x. Epub 2010 Nov 19. Am J Reprod Immunol. 2011. PMID: 21087338 Free PMC article. Review.

10

Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.

Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland RS, Overbaugh J. Piantadosi A, et al. Among authors: blish ca. J Virol. 2009 Oct;83(19):10269-74. doi: 10.1128/JVI.01149-09. Epub 2009 Jul 29. J Virol. 2009. PMID: 19640996 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page